Data / Form D filings / Cardurion Pharmaceuticals, Inc.
Cardurion Pharmaceuticals, Inc.: Form D filings
Cardurion Pharmaceuticals, Inc., a biotechnology company in Burlington, MA, filed 6 Form D notices with the SEC between 2017 and 2024. The latest, on July 24, 2024, reports $260.4 million sold of a $260.4 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 78 BLANCHARD ROAD, SUITE 200, Burlington, MA, 01803
- Phone
- (617) 996-1433
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1702453
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 24, 2024 | New notice | $260,410,720 | $260,410,720 | 19 | Jul 10, 2024 | sec.gov | |
| Jul 14, 2023 | Amendment | $128,125,000 | $128,125,000 | 2 | Oct 19, 2021 | sec.gov | |
| Dec 30, 2022 | New notice | $17,500,000 | $17,500,000 | 2 | Dec 16, 2022 | sec.gov | |
| Nov 3, 2021 | New notice | $128,125,000 | $46,125,000 | $82,000,000 | 2 | Oct 19, 2021 | sec.gov |
| Nov 20, 2019 | New notice | $10,000,000 | $10,000,000 | 2 | Nov 5, 2019 | sec.gov | |
| Apr 4, 2017 | New notice | $22,450,000 | $15,650,000 | $6,800,000 | 1 | Mar 20, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Evan Rachlin | Director | |
| Jeb Keiper | Director | |
| Michael Mendelsohn | Executive Officer, Director | |
| Daniel Lynch | Director | |
| Emma Reeve | Director | |
| Peter Lawrence | Executive Officer, Director | |
| Edward Mathers | Director | |
| Adam Koppel | Director | |
| Nicholas Downing | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 22, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cardurion Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.